Claraphi Advisory Network, LLC Neurocrine Biosciences Inc Transaction History
Claraphi Advisory Network, LLC
- $248 Million
- Q4 2022
Shares
2 transactions
Others Institutions Holding NBIX
# of Institutions
695Shares Held
102MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$2.2 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.52 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$862 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$692 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$478 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $14.8B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...